Skip to main content

Table 3 DAVID analysis functional annotation, gene ontology, 6-h and 12-h FX-9 exposure

From: Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line

GO.biological processes

6-h

12-h

DEGs

FDR

DEGs

FDR

inflammatory response

18

1.30E-04

12

2.70E-02

angiogenesis

14

1.30E-04

13

1.70E-04

positive regulation of cell migration

12

4.80E-04

11

6.00E-04

positive regulation of angiogenesis

10

4.80E-04

9

8.40E-04

I-kappaB kinase/NF-kappaB signaling

7

5.30E-03

  

negative regulation of cell proliferation

15

5.30E-03

  

positive regulation of NF-kappaB transcription factor activity

9

7.40E-03

  

positive regulation of transcription from RNA polymerase II promoter

24

8.00E-03

  

extracellular matrix organization

10

1.40E-02

10

4.80E-03

negative regulation of apoptotic process

15

1.40E-02

14

9.40E-03

cell adhesion

15

1.40E-02

  

positive regulation of nitric-oxide synthase biosynthetic process

4

2.50E-02

  

positive regulation of ERK1 and ERK2 cascade

9

2.70E-02

  

G1/S transition of mitotic cell cycle

  

9

6.00E-04

positive regulation of endothelial cell proliferation

  

6

2.70E-02